NeoGenomics, Inc. (NEO)
12.80
+0.12
(+0.99%)
USD |
NASDAQ |
Jan 08, 12:42
NeoGenomics Market Cap: 1.656B for Jan. 8, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| IQVIA Holdings, Inc. | 41.48B |
| Incyte Corp. | 20.95B |
| Regeneron Pharmaceuticals, Inc. | 85.46B |
| Arcturus Therapeutics Holdings, Inc. | 190.36M |
| Fortrea Holdings, Inc. | 1.613B |
Market Cap Related Metrics
| PS Ratio | 2.305 |
| PEG Ratio | -0.3256 |
| Price to Book Value | 1.975 |
| Price | 12.80 |
| Earnings Yield | -6.94% |
| PEGY Ratio | -0.3256 |